Compound Healthcare Ltd – Trademark Portfolio

Entity Type: 03

Compound Healthcare Ltd holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 1 filings in this category. The portfolio also extends into Class 18 (Leather Goods) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include COMPOUND HEALTHCARE. The owner is based in Dallas, TX.

1910 Pacific Ave, Suite 2000

Dallas, TX 75201

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Compound Healthcare Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

18
Leather Goods (1 filing)

Leather and imitations of leather; animal skins, hides; trunks and travelling bags

Frequently Asked Questions

How many trademarks does Compound Healthcare Ltd have?

Compound Healthcare Ltd has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does Compound Healthcare Ltd file in?

Compound Healthcare Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 18 (Leather Goods). Class 35 covers advertising; business management; business administration; office functions.

What are Compound Healthcare Ltd's most well-known trademarks?

Compound Healthcare Ltd's registered trademark portfolio includes well-known marks such as COMPOUND HEALTHCARE. These are among 1 currently registered trademark in the portfolio.

What is Compound Healthcare Ltd's trademark registration success rate?

Compound Healthcare Ltd has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.